Arrowstreet Capital’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.3M Buy
428,868
+140,150
+49% +$5.04M 0.01% 890
2026
Q1
$9.27M Buy
288,718
+89,067
+45% +$3.27M 0.01% 964
2025
Q4
$7.66M Buy
199,651
+172,674
+640% +$3.79M ﹤0.01% 1013
2025
Q3
$370K Sell
26,977
-18,467
-41% -$217K ﹤0.01% 1732
2025
Q2
$587K Hold
45,444
– – ﹤0.01% 1719
2025
Q1
$511K Sell
45,444
-26,811
-37% -$352K ﹤0.01% 1624
2024
Q4
$947K Buy
+72,255
New +$1.85M ﹤0.01% 1468

Other funds holding PACS

Arrowstreet Capital's PACS Position: Q2 2026 in Review

Arrowstreet Capital increased its PACS Group (PACS) stake by 49% in Q2 2026, buying an estimated $5.04M and bringing the position to 428,868 shares worth $18.3M. The position accounts for 0.01% of the portfolio, ranked #890.

Arrowstreet Capital first reported a position in PACS in Q4 2024 and has held it in 7 quarters since. 239 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • Arrowstreet Capital held 428,868 shares of PACS Group worth $18.3M as of Q2 2026.
  • Arrowstreet Capital bought 140,150 PACS Group shares in Q2 2026, an estimated $5.04M.
  • PACS Group made up 0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #890 holding.
  • Arrowstreet Capital first reported a position in PACS Group in Q4 2024 and has held it in 7 quarters since.
  • 239 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.